| Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana MA Huestis, JE Henningfield, EJ Cone Journal of analytical Toxicology 16 (5), 276-282, 1992 | 738 | 1992 |
| Establishing a nicotine threshold for addiction--the implications for tobacco regulation NL Benowitz, JE Henningfield New England Journal of Medicine 331 (2), 123-125, 1994 | 645 | 1994 |
| Nicotine medications for smoking cessation JE Henningfield New England Journal of Medicine 333 (18), 1196-1203, 1995 | 607 | 1995 |
| Nicotine delivery kinetics and abuse liability. JE Henningfield, RM Keenan Journal of consulting and clinical psychology 61 (5), 743, 1993 | 562 | 1993 |
| The development of a cocaine craving questionnaire ST Tiffany, E Singleton, CA Haertzen, JE Henningfield Drug and alcohol dependence 34 (1), 19-28, 1993 | 494 | 1993 |
| Higher levels of nicotine in arterial than in venous blood after cigarette smoking JE Henningfield, JM Stapleton, NL Benowitz, RF Grayson, ED London Drug and alcohol dependence 33 (1), 23-29, 1993 | 494 | 1993 |
| Nicotine and smoking: a review of effects on human performance. SJ Heishma, RC Taylor, JE Henningfield Experimental and Clinical Psychopharmacology 2 (4), 345, 1994 | 493 | 1994 |
| Epidemiology of tobacco use and dependence. GA Giovino, JE Henningfield, SL Tomar, LG Escobedo, J Slade Epidemiologic reviews 17 (1), 48-65, 1995 | 451 | 1995 |
| Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. JE Henningfield, K Miyasato, DR Jasinski Journal of Pharmacology and Experimental Therapeutics 234 (1), 1-12, 1985 | 399 | 1985 |
| Pharmacotherapy for Nicotine Dependence 1 JE Henningfield, RV Fant, AR Buchhalter, ML Stitzer CA: a cancer journal for clinicians 55 (5), 281-299, 2005 | 367 | 2005 |
| The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act MW Johnson, RR Griffiths, PS Hendricks, JE Henningfield Neuropharmacology 142, 143-166, 2018 | 363 | 2018 |
| The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. RJ Lamb, KL Preston, CW Schindler, RA Meisch, F Davis, JL Katz, ... The Journal of pharmacology and experimental therapeutics 259 (3), 1165-1173, 1991 | 363 | 1991 |
| Involvement of tobacco in alcoholism and illicit drug use JE Henningfield, R Clayton, W Pollin British journal of addiction 85 (2), 279-292, 1990 | 330 | 1990 |
| Health risks associated with cigar smoking F Baker, SR Ainsworth, JT Dye, C Crammer, MJ Thun, D Hoffmann, ... Jama 284 (6), 735-740, 2000 | 318 | 2000 |
| Nicotine as a reinforcer in human subjects and laboratory animals JE Henningfield, SR Goldberg Pharmacology Biochemistry and Behavior 19 (6), 989-992, 1983 | 272 | 1983 |
| The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US M Zeller, D Hatsukami Tobacco control 18 (4), 324-332, 2009 | 253 | 2009 |
| Psychedelics: Where we are now, why we got here, what we must do SJ Belouin, JE Henningfield Neuropharmacology 142, 7-19, 2018 | 247 | 2018 |
| The reemergence of smokeless tobacco. GN Connolly, DM Winn, SS Hecht, JE Henningfield, B Walker Jr, ... The New England Journal of Medicine 314 (16), 1020-1027, 1986 | 247 | 1986 |
| Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9 … MA Huestis, JE Henningfield, EJ Cone Journal of analytical toxicology 16 (5), 283-290, 1992 | 242 | 1992 |
| Reducing the nicotine content to make cigarettes less addictive NL Benowitz, JE Henningfield Tobacco control 22 (suppl 1), i14-i17, 2013 | 235 | 2013 |
